Pharmaceutical giant Novartis has concluded a major law firm panel review, with magic circle trio Allen & Overy (A&O), Freshfields Bruckhaus Deringer and Linklaters winning places on the company’s new global line-up.

The other firms on the global panel are Morrison & Foerster and White & Case. Meanwhile, Covington & Burling will provide specialist advice on pharma regulatory matters on a global basis, with McDermott Will & Emery doing likewise for intellectual property litigation.